The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Improving Outcome after Stroke: Overcoming the Translational Roadblock
Open accessAbstract
Stroke poses a massive burden of disease, yet we have few effective therapies. The paucity of therapeutic options stands contrary to intensive research efforts. The failure of these past investments demands a thorough re-examination of the pathophysiology of ischaemic brain injury. Several critical areas hold the key to overcoming the translational roadblock: (1) vascular occlusion: current recanalization strategies have limited effectiveness and may have serious side effects; (2) complexity of stroke pathobiology: therapy must acknowledge the ‘Janus-faced’ nature of many stroke targets and must identify endogenous neuroprotective and repair mechanisms; (3) inflammation and brain-immune-system interaction: inflammation contributes to lesion expansion, but is also instrumental in lesion containment and repair; stroke outcome is modulated by the interaction of the injured brain with the immune system; (4) regeneration: the potential of the brain for reorganization, plasticity and repair after injury is much greater than previously thought; (5) confounding factors, long-term outcome and predictive modelling. These 5 areas are linked on all levels and therefore need to be tackled by an integrative approach and innovative therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
Neuronal replacement from endogenous precursors in the adult brain after stroke
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., & Lindvall, O. (2002) · Nature Medicine · doi:10.1038/nm747 · Cited by 2,799
Self-citationInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Self-citation1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.
Astrup, J., Symon, L., Branston, N. M., & Lassen, N. A. (1977) · Stroke · doi:10.1161/01.str.8.1.51 · Cited by 1,120
Jin, K., Minami, M., Lan, J. Q., Mao, X. O., Batteur, S., Simon, R. P., & Greenberg, D. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081011098 · Cited by 1,051
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
Alexandrov, A. V., Molina, C. A., Grotta, J. C., Garami, Z., Ford, S. R., Alvarez-Sabin, J., Montaner, J., Saqqur, M., Demchuk, A. M., Moyé, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041175 · Cited by 1,046
Bright and dark sides of nitric oxide in ischemic brain injury
Iadecola, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10074-6 · Cited by 1,046
Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., & Koistinaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,038
Self-citationRat forebrain neurogenesis and striatal neuron replacement after focal stroke
Parent, J. M., Vexler, Z. S., Gong, C., Derugin, N., & Ferriero, D. M. (2002) · Annals of Neurology · doi:10.1002/ana.10393 · Cited by 1,024
Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E. F., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R.-L., Bartke, I., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.865 · Cited by 1,019
Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice
Eglitis, M. A., & Mezey, É. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4080 · Cited by 1,016
Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., et al. (2005) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Self-citationCentral nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968
Self-citationStem cells for the treatment of neurological disorders
Lindvall, O., & Kokaia, Z. (2006) · Nature · doi:10.1038/nature04960 · Cited by 829
Self-citationDerivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803
Ischemic tolerance and endogenous neuroprotection
Dirnagl, U., Simon, R. P., & Hallenbeck, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00071-7 · Cited by 791
Self-citationAdministration of CD34+ cells after stroke enhances neurogenesis via angiogenesisin a mouse model
Taguchi, A., Soma, T., Tanaka, H., Kanda, T., Nishimura, H., Yoshikawa, H., Tsukamoto, Y., Iso, H., Fujimori, Y., Stern, D. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420622 · Cited by 784
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E. T., Vivien, D., & Buisson, A. (2001) · Nature Medicine · doi:10.1038/83358 · Cited by 735
Self-citationPooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias
Macleod, M. R., O’Collins, T., Howells, D. W., & Donnan, G. A. (2004) · Stroke · doi:10.1161/01.str.0000125719.25853.20 · Cited by 730
Role of matrix metalloproteinases in delayed cortical responses after stroke
Zhao, B.-Q., Wang, S., Kim, H.-Y., Storrie, H., Rosen, B. R., Mooney, D. J., Wang, X., & Lo, E. H. (2006) · Nature Medicine · doi:10.1038/nm1387 · Cited by 702
Schneider, A., Krüger, C., Steigleder, T., Weber, D., Pitzer, C., Laage, R., Aronowski, J., Maurer, M. H., Gassler, N., Mier, W., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23559 · Cited by 690
The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms
Engelhardt, B., & Ransohoff, R. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.07.004 · Cited by 673
Self-citationExcitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator
Tsirka, S. E., Gualandris, A., Amaral, D. G., & Strickland, S. (1995) · Nature · doi:10.1038/377340a0 · Cited by 663
NXY-059 for Acute Ischemic Stroke
Lees, K. R., Zivin, J. A., Ashwood, T., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J., Lyden, P., Shuaib, A., Hårdemark, H.-G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052980 · Cited by 660 · cited 1×
“The latest of these, SAINT-II (Stroke Acute Ischaemic NXY Treatment, testing the free radical spin trap agent NXY-059) and DIAS-2 (Desmoteplase in Acute Ischaemic Stroke, testing the vampire bat plasminogen activator desmoteplase), showed no efficacy even though there were extensive and convincing preclinical as well…”
MethodPriller, J., Flügel, A., Wehner, T., Boentert, M., Haas, C. A., Prinz, M., Fernández-Klett, F., Prass, K., Bechmann, I., de Boer, B. A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1356 · Cited by 637
Self-citationEvidence for stroke-induced neurogenesis in the human brain
Jin, K., Wang, X., Xie, L., Mao, X. O., Zhu, W., Wang, Y., Shen, J., Mao, Y., Banwait, S., & Greenberg, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603512103 · Cited by 628
Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., & Sorokin, L. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051342 · Cited by 559
Stroke-Induced Immunodepression: Experimental Evidence and Clinical Relevance
Dirnagl, U., Klehmet, J., Braun, J. S., Harms, H., Meisel, C., Ziemssen, T., Prass, K., & Meisel, A. (2007) · Stroke · doi:10.1161/01.str.0000251441.89665.bc · Cited by 473
Self-citationKidwell, C. S., Alger, J. R., & Saver, J. L. (2003) · Stroke · doi:10.1161/01.str.0000097608.38779.cc · Cited by 473
Iosif, R. E., Ekdahl, C. T., Ahlenius, H., Pronk, C. J. H., Bonde, S., Kokaia, Z., Jacobsen, S.-E. W., & Lindvall, O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2723-06.2006 · Cited by 463
Self-citationA randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 445
The early events of oxygen and glucose deprivation: setting the scene for neuronal death?
Martin, R. L., Lloyd, H. G. E., & Cowan, A. I. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90008-6 · Cited by 404
Zhang, R., Zhang, Z., Wang, L., Wang, Y., Gousev, A., Zhang, L., Ho, K.-L., Morshead, C., & Chopp, M. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200404000-00009 · Cited by 381
Vajkoczy, P., Laschinger, M., & Engelhardt, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12440 · Cited by 357
Self-citationMechanisms of neural plasticity following brain injury
Wieloch, T., & Nikolich, K. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.011 · Cited by 349
Self-citationWegener, S., Gottschalk, B., Jovanovic, V., Knab, R., Fiebach, J. B., Schellinger, P. D., Kucinski, T., Jungehülsing, G. J., Brunecker, P., Müller, B., et al. (2004) · Stroke · doi:10.1161/01.str.0000115767.17923.6a · Cited by 303
Collateral Growth and Angiogenesis Around Cortical Stroke
Wei, L., Erinjeri, J. P., Rovainen, C. M., & Woolsey, T. A. (2001) · Stroke · doi:10.1161/hs0901.094282 · Cited by 301
Do transient ischemic attacks have a neuroprotective effect?
Moncayo, J., de Freitas, G. R., Bogousslavsky, J., Altieri, M., & van Melle, G. (2000) · Neurology · doi:10.1212/wnl.54.11.2089 · Cited by 285
Role of glial cells in cerebral ischemia
Nedergaard, M., & Dirnagl, U. (2005) · Glia · doi:10.1002/glia.20205 · Cited by 285
Self-citationNeuronal Apoptosis After CNS Injury: The Roles of Glutamate and Calcium
ZIPFEL, G. J., BABCOCK, D. J., LEE, J.-M., & CHOI, D. W. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.857 · Cited by 281
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
Targeting eNOS for stroke protection
Endres, M., Laufs, U., Liao, J. K., & Moskowitz, M. A. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.009 · Cited by 266
Self-citationIKK mediates ischemia-induced neuronal death
Herrmann, O., Baumann, B., de Lorenzi, R., Muhammad, S., Zhang, W., Kleesiek, J., Malfertheiner, M., Köhrmann, M., Potrovita, I., Maegele, I., et al. (2005) · Nature Medicine · doi:10.1038/nm1323 · Cited by 259
Self-citationRole of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation
Zhuo, M., Holtzman, D. M., Li, Y., Osaka, H., DeMaro, J., Jacquin, M., & Bu, G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00542.2000 · Cited by 258
Gertz, K., Priller, J., Kronenberg, G., Fink, K. B., Winter, B., Schröck, H., Ji, S., Milosevic, M., Harms, C., Böhm, M., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000250175.14861.77 · Cited by 252
Self-citationPapadopoulos, C. M., Tsai, S., Alsbiei, T., O'Brien, T. E., Schwab, M. E., & Kartje, G. L. (2002) · Annals of Neurology · doi:10.1002/ana.10144 · Cited by 249 · cited 1×
“by inactivation of the Nogo-A/NgR signalling system [ 59 ] , the tophic factors erythropoietin and granulocyte colony-stimulating factor [60, 61] , or potentially activators of the basal forebrain cholinergic system, such as cholinesterase inhibitors [62] .”
MethodSelf-citationNimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review
Horn, J., de Haan, R. J., Vermeulen, M., Luiten, P. G. M., & Limburg, M. (2001) · Stroke · doi:10.1161/hs1001.096009 · Cited by 230
Conner, J. M., Chiba, A. A., & Tuszynski, M. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.003 · Cited by 223
Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., & Hoch, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4271 · Cited by 203 · cited 1×
“In order to understand which leucocyte subpopulations confer beneficial rather than detrimental effects, it is mandatory to understand first the multi-step recruitment cascade of leucocyte subpopulations across the BBB [31] . To date, these processes have been investigated mostly during auto-immune CNS inflammation […”
BackgroundSelf-citationWillmot, M., Gray, L., Gibson, C., Murphy, S., & Bath, P. M. W. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.01.003 · Cited by 179
The Ischemic Penumbra: Identification, Evolution and Treatment Concepts
Fisher, M. (2003) · Cerebrovascular Diseases · doi:10.1159/000074790 · Cited by 177
Bernabeu, R., & Sharp, F. R. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00006 · Cited by 171
Animal models of stroke: do they have value for discovering neuroprotective agents?
Richard Green, A., Odergren, T., & Ashwood, T. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00192-5 · Cited by 168
Kaczmarek, L., Dzwonek, J., & Szymczak, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf676 · Cited by 157
Fernández‐Monreal, M., López‐Atalaya, J. P., Benchenane, K., Cacquevel, M., Dulin, F., Caër, J. L., Rossier, J., Jarrige, A.-C., MacKenzie, E. T., Colloc’h, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407069200 · Cited by 151
Self-citationSavitz, S. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.003 · Cited by 133
Neuroprotection Is Unlikely to Be Effective in Humans Using Current Trial Designs
Grotta, J. C. (2002) · Stroke · doi:10.1161/str.33.1.306 · Cited by 117
Local Cerebral Blood Flow and Vascular Reactivity in a Chronic Stable Stroke in Baboons
SYMON, L., CROCKARD, H. A., C.DORSCH, N. W., BRANSTON, N. M., & JUHASZ, J. (1975) · Stroke · doi:10.1161/01.str.6.5.482 · Cited by 114
Equivocal roles of tissue-type plasminogen activator in stroke-induced injury
Benchenane, K., López‐Atalaya, J. P., Fernández‐Monreal, M., Touzani, O., & Vivien, D. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2003.12.011 · Cited by 106
Self-citationThe Ischemic Penumbra: A New Opportunity for Neuroprotection
Fisher, M. (2006) · Cerebrovascular Diseases · doi:10.1159/000091705 · Cited by 63
Life After Cerovive: A Personal Perspective on Ischemic Neuroprotection in the Post–NXY-059 Era
Ginsberg, M. D. (2007) · Stroke · doi:10.1161/strokeaha.106.479170 · Cited by 57
Neurorepair versus Neuroprotection in Stroke
Hurtado, O., Pradillo, J. M., Alonso‐Escolano, D., Lorenzo, P., Sobrino, T., Castillo, J., Lizasoaín, I., & Moro, M. Á. (2006) · Cerebrovascular Diseases · doi:10.1159/000091704 · Cited by 51
Cited by
Pathophysiology and treatment of stroke: present status and future perspectives
Kuriakose, D., & Xiao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207609 · Cited by 1,350
Harnessing neuroplasticity for clinical applications
Cramer, S. C., Sur, M., Dobkin, B. H., O'Brien, C., Sanger, T. D., Trojanowski, J. Q., Rumsey, J. M., Hicks, R., Cameron, J., Chen, D., et al. (2011) · Brain · doi:10.1093/brain/awr039 · Cited by 1,259
“Numerous probes exist to assess the nervous system in this regard (Endres et al., 2008), many of which have been discussed above.”
Ischemic stroke: experimental models and reality
Sommer, C. J. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1667-0 · Cited by 599
Stroke and the immune system: from pathophysiology to new therapeutic strategies
Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., & Vivien, D. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70066-7 · Cited by 560
Self-citationInflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation
Denes, A., Thornton, P., Rothwell, N. J., & Allan, S. M. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.010 · Cited by 309
Self-citation
Metadata
- Authors
- Endres, M., Engelhardt, B., Koistinaho, J., Lindvall, O., Meairs, S., Mohr, J. P., Planas, A., Rothwell, N., Schwaninger, M., Schwab, M. E., Vivien, D., Wieloch, T., & Dirnagl, U.
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 25
- Issue
- 3
- Pages
- 268-278
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W2044671618
- Cited by
- 258
- References
- 68
- FWCI
- 16.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.